A practical reference on metabolic research: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-12 and is reviewed periodically as new material appears.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide fragment | Not a full hormone |
| Molecular target | Proposed adipose tissue lipolysis | Receptor details uncertain |
| Typical research dose | Not established for clinical use | Doses vary across studies |
| Stability in solution | Limited; store cold | Avoid repeated freeze-thaw |
| Regulatory status | Not approved as a drug | Varies by country |
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
=== Differences from deepfakes === Although AI-generated pornography and deepfake pornography rely on similar generative AI technologies, deepfakes involve altering existing content, usually photographs of unconsenting individuals, while AI-generated pornography usually synthesizes explicit content from scratch without using people's likenesses directly. Digital image analysis expert Hany Farid opined that, while deepfake pornography of unconsenting individuals should be illegal, the legal status of AI-generated pornography created from scratch is "more complex".
Evidence indicating that Early to Middle Pleistocene hominins from the northern Indian Subcontinent lived in a mosaic environment dominated by savannas is presented by Kaur et al. (2026). Tu et al. (2026) determine the three crania of Homo erectus from the Yunxian site (Hubei, China) to be approximately 1.77 million years old, representing the oldest securely dated hominin fossils from eastern Asia reported to date. Gousset et al. (2026) study the phylogenetic relationships of Homo luzonensis, and interpret the studied hominin as most likely originating from an Asian population of Homo erectus, resulting in evolutionary reversals in an insular context and likely caused by living in tropical environment. A study on the technological characteristics of the stone tools from the Rizal Archaeological Site (Philippines) is published by Guibert et al. (2026). Li et al. (2026) report a new Lower Paleolithic site with stone tools and animal remains (the Daanmiao site) in the Bailong River valley (Gansu, China) providing evidence of hominin occupation of western Qinling Mountain Ranges approximately 900,000 years ago, and evidence of more favorable habitat for early hominins in the studied area than in other parts of North China during the Mid-Pleistocene Transition. Shao et al. (2026) determine two hominin crania from the Hulu Cave (China) to likely fall within a similar chronological range and date them to Marine Isotope Stage 16. Fu et al.
== Composition == Petroleum consists of a variety of liquid, gaseous, and solid components. Lighter hydrocarbons are the gases methane, ethane, propane and butane. Otherwise the bulk of the liquid and solids are largely heavier organic compounds, often hydrocarbons (C and H only). The proportion of light hydrocarbons in a petroleum mixture varies among oil fields. An oil well produces predominantly crude oil. Because the pressure is lower at the surface than underground, some of the gas will come out of solution and be recovered (or burned) as associated gas or solution gas. A gas well produces predominantly natural gas. However, because the underground temperature is higher than at the surface, the gas may contain heavier hydrocarbons such as pentane, hexane, and heptane ("natural-gas condensate", often shortened to condensate.) Condensate resembles gasoline in appearance and is similar in composition to some volatile light crude oils. The hydrocarbons in crude oil are mostly alkanes, cycloalkanes and various aromatic hydrocarbons, while the other organic compounds contain nitrogen, oxygen, and sulfur, and traces of metals such as iron, nickel, copper and vanadium. Many oil reservoirs contain live bacteria. The molecular composition of crude oil varies widely from formation to formation, but the proportion of chemical elements varies over fairly narrow limits as follows:
=== Colonial Police Medal (CPM) === Chan Pak-chi, Superintendent, Royal Hong Kong Police Force. Albert Chan Ting-kai, Senior Divisional Officer, Royal Hong Kong Police Force. Chan Yun-pui, Senior Divisional Officer, Royal Hong Kong Police Force. Cheung Yuk-fung, Superintendent, Royal Hong Kong Police Force. Paul Croft, Senior Superintendent, Royal Hong Kong Police Force. William Frederick Fenton, Senior Superintendent, Royal Hong Kong Police Force. Gillian Suk-han Fletcher, Chief Inspector, Royal Hong Kong Police Force. Fu Keung San-ling, Sergeant, Royal Hong Kong Police Force. Barry Christopher Griffin, Senior Superintendent, Royal Hong Kong Police Force. Tony Ho Tse-tong, Senior Superintendent, Royal Hong Kong Police Force. Victor Hsu Yung, Senior Divisional Officer, Royal Hong Kong Police Force. Kwan Wa-fai, Station Sergeant, Royal Hong Kong Police Force. Lee Yeung-chi, Superintendent, Royal Hong Kong Police Force. Leung Ping, Station Sergeant, Royal Hong Kong Police Force. Li Chun-wai, Station Sergeant, Royal Hong Kong Police Force. Li Kam-wa, Station Sergeant, Royal Hong Kong Police Force. Li Mau-sau, Station Sergeant, Royal Hong Kong Police Force. Liu Tin-chee, Senior Divisional Officer, Royal Hong Kong Police Force. Lo Chan Lin, Station Sergeant, Royal Hong Kong Police Force. Kenneth William Colin Mackenzie, Superintendent, Royal Hong Kong Police Force. Edward Mak Man-poon, Senior Superintendent, Royal Hong Kong Police Force. Martin Samson, Senior Superintendent, Royal Hong Kong Police Force. Tam Sum-wing, Station Sergeant, Royal Hong Kong Police Force.
=== Rare reactions === Aside from hyperkalemia, spironolactone may rarely cause adverse reactions such as anaphylaxis, kidney failure, hepatitis (two reported cases, neither serious), agranulocytosis, DRESS syndrome, Stevens–Johnson syndrome, or toxic epidermal necrolysis. Five cases of breast cancer in patients who took spironolactone for prolonged periods of time have been reported.
Sources: en.wikipedia.org
== Structure == ATP consists of three parts: a sugar, an amine base, and a phosphate group. More specifically, ATP consists of an adenine attached by the #9-nitrogen atom to the 1′ carbon atom of a sugar (ribose), which in turn is attached at the 5' carbon atom of the sugar to a triphosphate group. In its many reactions related to metabolism, the adenine and sugar groups remain unchanged, but the triphosphate is converted to di- and monophosphate, giving respectively the derivatives ADP and AMP. The three phosphoryl groups are labeled as alpha (α), beta (β), and, for the terminal phosphate, gamma (γ). In neutral solution, ionized ATP exists mostly as ATP4−, with a small proportion of ATP3−.
A new Familia 1000 coupé arrived in November 1965, with a 985 cc SOHC "PC" engine, and was joined by the larger Mazda Luce in 1966. Around the same time, the 800 engine was upgraded, adding three horsepower. As a number of new 1-litre vehicles were introduced by Mazda's competitors, another 987 cc OHV engine (PB) appeared in January 1967, powering new 1000 saloon and van versions. The 1-litre saloons and vans are recognizable by their broader, rounded-off rectangular headlights. Production of the saloon continued until November 1967, while the van versions continued until they were replaced in February 1968. Around 400,000 of the first Familias were built, 130,473 of which were saloons and coupés. Around 10,000 of the first generation Familias were exported, mainly to Australia and Oceania.
Mathematical descriptions of protein-DNA binding taking into account sequence-specificity, and competitive and cooperative binding of proteins of different types are usually performed with the help of the lattice models. Computational methods to identify the DNA binding sequence specificity have been proposed to make a good use of the abundant sequence data in the post-genomic era. In addition, progress has happened on structure-based prediction of binding specificity across protein families using deep learning.
Killed Arpad Horvath (75) at Meadow Park facility in London, Ontario Injected Sandra Towler (77) "with intent to murder" at a retirement home in Paris, Ontario Injected Beverly Bertram (68) "with intent to murder" at a private residence in Ingersoll, Ontario
Sources: en.wikipedia.org
== Treatment == Treatment for neurofibrosarcoma is similar to that of other cancers. Surgery is an option; the removal of the tumor along with surrounding tissue may be vital for the patient's survival. For discrete, localized tumors, surgery is often followed by radiation therapy of the excised area to reduce the chance of recurrence. For patients who have neurofibrosarcomas in an extremity, if the tumor is vascularized (has its own blood supply) and has many nerves going through it and/or around it, amputation of the extremity may be necessary. Some surgeons argue that amputation should be the procedure of choice when possible, due to the increased chance of a better quality of life. Otherwise, surgeons may opt for a limb-saving treatment, by removing less of the surrounding tissue or part of the bone, which is replaced by a metal rod or grafts. Radiation will also be used in conjunction with surgery, especially if the limb was not amputated. Radiation is rarely used as a sole treatment. In some instances, the oncologist may choose chemotherapy drugs when treating a patient with neurofibrosarcoma, usually in conjunction with surgery. Patients taking chemotherapy must be prepared for the side effects that come with any other chemotherapy treatment, such as; hair loss, lethargy, weakness, etc.
Many developed countries specify standards to be applied in their own country. In Europe, this includes the European Drinking Water Directive and in the United States the United States Environmental Protection Agency (EPA) establishes standards as required by the Safe Drinking Water Act. For countries without a legislative or administrative framework for such standards, the World Health Organization publishes guidelines on the standards that should be achieved. China adopted its own drinking water standard GB3838-2002 (Type II) enacted by Ministry of Environmental Protection in 2002. Where drinking water quality standards do exist, most are expressed as guidelines or targets rather than requirements, and very few water standards have any legal basis or, are subject to enforcement. Two exceptions are the European Drinking Water Directive and the Safe Drinking Water Act in the United States, which require legal compliance with specific standards.
14 January During Operation Toan Thang II a convoy of the 48th Transportation Group was ambushed in Tây Ninh Province, 122 PAVN/VC were killed and three individual and one crew-served weapons were captured; U.S. losses were seven killed.
Sources: en.wikipedia.org
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.
Because it is a fragment rather than full growth hormone, it is generally described as lacking growth-promoting effects. Some studies suggest it may influence fat metabolism without the same systemic growth effects, though evidence is limited.
Human trials have measured body weight, fat mass, lean mass, lipid levels, and adverse events. Most have been small or short-term, so conclusions about long-term outcomes are limited.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.